134 related articles for article (PubMed ID: 14688623)
1. Time window of fibroblast growth factor-18-mediated neuroprotection after occlusion of the middle cerebral artery in rats.
Ellsworth JL; Garcia R; Yu J; Kindy MS
J Cereb Blood Flow Metab; 2004 Jan; 24(1):114-23. PubMed ID: 14688623
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor-18 reduced infarct volumes and behavioral deficits after transient occlusion of the middle cerebral artery in rats.
Ellsworth JL; Garcia R; Yu J; Kindy MS
Stroke; 2003 Jun; 34(6):1507-12. PubMed ID: 12738892
[TBL] [Abstract][Full Text] [Related]
3. Effects of intraventricular infusion of vascular endothelial growth factor on cerebral blood flow, edema, and infarct volume.
Harrigan MR; Ennis SR; Sullivan SE; Keep RF
Acta Neurochir (Wien); 2003 Jan; 145(1):49-53. PubMed ID: 12545262
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective efficacy and therapeutic time window of peroxynitrite decomposition catalysts in focal cerebral ischemia in rats.
Thiyagarajan M; Kaul CL; Sharma SS
Br J Pharmacol; 2004 Jul; 142(5):899-911. PubMed ID: 15197101
[TBL] [Abstract][Full Text] [Related]
5. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
[TBL] [Abstract][Full Text] [Related]
6. The quantitative assessment of functional impairment and its correlation to infarct volume in rats with transient middle cerebral artery occlusion.
Lim SH; Lee JS; Lee JI; Im S; Ko YJ; Kim HW
Brain Res; 2008 Sep; 1230():303-9. PubMed ID: 18675259
[TBL] [Abstract][Full Text] [Related]
7. An improved post-operative care protocol allows detection of long-term functional deficits following MCAo surgery in rats.
Ryan CL; Doucette TA; Gill DA; Langdon KD; Liu Y; Perry MA; Tasker RA
J Neurosci Methods; 2006 Jun; 154(1-2):30-7. PubMed ID: 16423407
[TBL] [Abstract][Full Text] [Related]
8. Combined magnesium and mild hypothermia (35 degrees C) treatment reduces infarct volumes after permanent middle cerebral artery occlusion in the rat at 2 and 4, but not 6 h.
Campbell K; Meloni BP; Knuckey NW
Brain Res; 2008 Sep; 1230():258-64. PubMed ID: 18644354
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic time window and dose dependence of neuroprotective effects of sodium orthovanadate following transient middle cerebral artery occlusion in rats.
Hasegawa Y; Morioka M; Hasegawa S; Matsumoto J; Kawano T; Kai Y; Yano S; Fukunaga K; Kuratsu J
J Pharmacol Exp Ther; 2006 May; 317(2):875-81. PubMed ID: 16461588
[TBL] [Abstract][Full Text] [Related]
10. The Neuroprotection of puerarin against cerebral ischemia is associated with the prevention of apoptosis in rats.
Xu X; Zhang S; Zhang L; Yan W; Zheng X
Planta Med; 2005 Jul; 71(7):585-91. PubMed ID: 16041641
[TBL] [Abstract][Full Text] [Related]
11. Human umbilical cord blood cells do not improve sensorimotor or cognitive outcome following transient middle cerebral artery occlusion in rats.
Mäkinen S; Kekarainen T; Nystedt J; Liimatainen T; Huhtala T; Närvänen A; Laine J; Jolkkonen J
Brain Res; 2006 Dec; 1123(1):207-15. PubMed ID: 17070789
[TBL] [Abstract][Full Text] [Related]
12. Effective plasma concentration of a novel Na+/Ca2+ channel blocker NS-7 for its cerebroprotective actions in rats with a transient middle cerebral artery occlusion.
Aoki Y; Tamura M; Itoh Y; Seto T; Nonaka K; Mukai H; Ukai Y
J Pharmacol Exp Ther; 2001 Feb; 296(2):306-11. PubMed ID: 11160611
[TBL] [Abstract][Full Text] [Related]
13. G-CSF reduces infarct volume and improves functional outcome after transient focal cerebral ischemia in mice.
Gibson CL; Bath PM; Murphy SP
J Cereb Blood Flow Metab; 2005 Apr; 25(4):431-9. PubMed ID: 15660101
[TBL] [Abstract][Full Text] [Related]
14. Two different molecular mechanisms underlying progesterone neuroprotection against ischemic brain damage.
Cai W; Zhu Y; Furuya K; Li Z; Sokabe M; Chen L
Neuropharmacology; 2008 Aug; 55(2):127-38. PubMed ID: 18572204
[TBL] [Abstract][Full Text] [Related]
15. Administration of transforming growth factor-alpha reduces infarct volume after transient focal cerebral ischemia in the rat.
Justicia C; Pérez-Asensio FJ; Burguete MC; Salom JB; Planas AM
J Cereb Blood Flow Metab; 2001 Sep; 21(9):1097-104. PubMed ID: 11524614
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of a novel herbal decoction on focal cerebral ischemia in a rodent model.
Kim MG; Choi JH; Lim JP; Kim DK; Shin TY; Boo Y; Kim SY; Kim H; Ha E; Park HK; Kim J; Lim HS; Kim EH; Kim JB; Leem KH
Neurol Res; 2007; 29 Suppl 1():S16-22. PubMed ID: 17359635
[TBL] [Abstract][Full Text] [Related]
17. Allopregnanolone, a progesterone metabolite, is more effective than progesterone in reducing cortical infarct volume after transient middle cerebral artery occlusion.
Sayeed I; Guo Q; Hoffman SW; Stein DG
Ann Emerg Med; 2006 Apr; 47(4):381-9. PubMed ID: 16546625
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotection by pyrroloquinoline quinone (PQQ) in reversible middle cerebral artery occlusion in the adult rat.
Zhang Y; Feustel PJ; Kimelberg HK
Brain Res; 2006 Jun; 1094(1):200-6. PubMed ID: 16709402
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effects of the novel polyethylene glycol-hemoglobin conjugate SB1 on experimental cerebral thromboembolism in rats.
Ji HJ; Chai HY; Nahm SS; Lee J; Bae GW; Nho K; Kim YB; Kang JK
Eur J Pharmacol; 2007 Jul; 566(1-3):83-7. PubMed ID: 17397828
[TBL] [Abstract][Full Text] [Related]
20. Dose dependence and therapeutic window for the neuroprotective effects of curcumin in thromboembolic model of rat.
Dohare P; Garg P; Jain V; Nath C; Ray M
Behav Brain Res; 2008 Nov; 193(2):289-97. PubMed ID: 18611416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
